Sharda Motor Industries Ltd. (SHARDAMOTR.BO) Stock Competitors & Peer Comparison
See (SHARDAMOTR.BO) competitors and their performances in Stock Market.
Peer Comparison Table: Auto - Parts Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SHARDAMOTR.BO | ₹869.60 | +4.60% | 49.9B | 9.46 | ₹91.94 | +1.95% |
| MOTHERSON.BO | ₹148.20 | -1.63% | 1.6T | 40.60 | ₹3.65 | +0.39% |
| MOTHERSON.NS | ₹148.11 | -1.63% | 1.6T | 40.16 | ₹3.69 | +0.39% |
| BOSCHLTD.NS | ₹39,900.00 | +0.04% | 1.2T | 42.32 | ₹942.92 | +1.28% |
| BOSCHLTD.BO | ₹39,895.75 | +0.00% | 1.2T | 42.46 | ₹939.62 | +1.28% |
| BHARATFORG.BO | ₹2,145.75 | -1.22% | 1T | 82.56 | ₹25.99 | +0.37% |
| BHARATFORG.NS | ₹2,144.10 | -1.23% | 1T | 82.18 | ₹26.09 | +0.37% |
| SCHAEFFLER.BO | ₹4,187.35 | +2.42% | 657.3B | 55.38 | ₹75.61 | +0.86% |
| SCHAEFFLER.NS | ₹4,189.70 | +2.38% | 654.9B | 58.09 | ₹72.13 | +0.86% |
| UNOMINDA.NS | ₹1,087.80 | -0.32% | 628.2B | 51.31 | ₹21.20 | +0.24% |
Stock Comparison
SHARDAMOTR.BO vs MOTHERSON.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, MOTHERSON.BO has a market cap of 1.6T. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while MOTHERSON.BO trades at ₹148.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas MOTHERSON.BO's P/E ratio is 40.60. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to MOTHERSON.BO's ROE of +0.10%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to MOTHERSON.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check MOTHERSON.BO's competition here
SHARDAMOTR.BO vs MOTHERSON.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, MOTHERSON.NS has a market cap of 1.6T. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while MOTHERSON.NS trades at ₹148.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas MOTHERSON.NS's P/E ratio is 40.16. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to MOTHERSON.NS's ROE of +0.10%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to MOTHERSON.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check MOTHERSON.NS's competition here
SHARDAMOTR.BO vs BOSCHLTD.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, BOSCHLTD.NS has a market cap of 1.2T. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while BOSCHLTD.NS trades at ₹39,900.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas BOSCHLTD.NS's P/E ratio is 42.32. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to BOSCHLTD.NS's ROE of +0.20%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to BOSCHLTD.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check BOSCHLTD.NS's competition here
SHARDAMOTR.BO vs BOSCHLTD.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, BOSCHLTD.BO has a market cap of 1.2T. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while BOSCHLTD.BO trades at ₹39,895.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas BOSCHLTD.BO's P/E ratio is 42.46. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to BOSCHLTD.BO's ROE of +0.20%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to BOSCHLTD.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check BOSCHLTD.BO's competition here
SHARDAMOTR.BO vs BHARATFORG.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, BHARATFORG.BO has a market cap of 1T. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while BHARATFORG.BO trades at ₹2,145.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas BHARATFORG.BO's P/E ratio is 82.56. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to BHARATFORG.BO's ROE of +0.12%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to BHARATFORG.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check BHARATFORG.BO's competition here
SHARDAMOTR.BO vs BHARATFORG.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, BHARATFORG.NS has a market cap of 1T. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while BHARATFORG.NS trades at ₹2,144.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas BHARATFORG.NS's P/E ratio is 82.18. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to BHARATFORG.NS's ROE of +0.12%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to BHARATFORG.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check BHARATFORG.NS's competition here
SHARDAMOTR.BO vs SCHAEFFLER.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, SCHAEFFLER.BO has a market cap of 657.3B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while SCHAEFFLER.BO trades at ₹4,187.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas SCHAEFFLER.BO's P/E ratio is 55.38. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to SCHAEFFLER.BO's ROE of +0.22%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to SCHAEFFLER.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check SCHAEFFLER.BO's competition here
SHARDAMOTR.BO vs SCHAEFFLER.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, SCHAEFFLER.NS has a market cap of 654.9B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while SCHAEFFLER.NS trades at ₹4,189.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas SCHAEFFLER.NS's P/E ratio is 58.09. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to SCHAEFFLER.NS's ROE of +0.22%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to SCHAEFFLER.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check SCHAEFFLER.NS's competition here
SHARDAMOTR.BO vs UNOMINDA.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, UNOMINDA.NS has a market cap of 628.2B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while UNOMINDA.NS trades at ₹1,087.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas UNOMINDA.NS's P/E ratio is 51.31. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to UNOMINDA.NS's ROE of +0.19%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to UNOMINDA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check UNOMINDA.NS's competition here
SHARDAMOTR.BO vs UNOMINDA.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, UNOMINDA.BO has a market cap of 627.2B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while UNOMINDA.BO trades at ₹1,087.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas UNOMINDA.BO's P/E ratio is 51.34. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to UNOMINDA.BO's ROE of +0.19%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to UNOMINDA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check UNOMINDA.BO's competition here
SHARDAMOTR.BO vs MRF.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, MRF.NS has a market cap of 542.1B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while MRF.NS trades at ₹127,820.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas MRF.NS's P/E ratio is 22.40. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to MRF.NS's ROE of +0.13%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to MRF.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check MRF.NS's competition here
SHARDAMOTR.BO vs MRF.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, MRF.BO has a market cap of 542B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while MRF.BO trades at ₹127,856.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas MRF.BO's P/E ratio is 22.13. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to MRF.BO's ROE of +0.13%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to MRF.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check MRF.BO's competition here
SHARDAMOTR.BO vs BALKRISIND.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, BALKRISIND.BO has a market cap of 422.2B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while BALKRISIND.BO trades at ₹2,182.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas BALKRISIND.BO's P/E ratio is 34.24. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to BALKRISIND.BO's ROE of +0.12%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to BALKRISIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check BALKRISIND.BO's competition here
SHARDAMOTR.BO vs BALKRISIND.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, BALKRISIND.NS has a market cap of 421.5B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while BALKRISIND.NS trades at ₹2,180.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas BALKRISIND.NS's P/E ratio is 31.95. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to BALKRISIND.NS's ROE of +0.12%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to BALKRISIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check BALKRISIND.NS's competition here
SHARDAMOTR.BO vs SONACOMS.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, SONACOMS.BO has a market cap of 386.6B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while SONACOMS.BO trades at ₹619.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas SONACOMS.BO's P/E ratio is 57.43. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to SONACOMS.BO's ROE of +0.11%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to SONACOMS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check SONACOMS.BO's competition here
SHARDAMOTR.BO vs SONACOMS.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, SONACOMS.NS has a market cap of 385.6B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while SONACOMS.NS trades at ₹619.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas SONACOMS.NS's P/E ratio is 56.87. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to SONACOMS.NS's ROE of +0.11%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to SONACOMS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check SONACOMS.NS's competition here
SHARDAMOTR.BO vs ENDURANCE.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, ENDURANCE.NS has a market cap of 376.1B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while ENDURANCE.NS trades at ₹2,673.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas ENDURANCE.NS's P/E ratio is 38.13. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to ENDURANCE.NS's ROE of +0.16%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to ENDURANCE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check ENDURANCE.NS's competition here
SHARDAMOTR.BO vs ENDURANCE.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, ENDURANCE.BO has a market cap of 375.8B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while ENDURANCE.BO trades at ₹2,673.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas ENDURANCE.BO's P/E ratio is 38.82. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to ENDURANCE.BO's ROE of +0.16%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to ENDURANCE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check ENDURANCE.BO's competition here
SHARDAMOTR.BO vs EXIDEIND.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, EXIDEIND.NS has a market cap of 328.6B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while EXIDEIND.NS trades at ₹387.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas EXIDEIND.NS's P/E ratio is 30.68. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to EXIDEIND.NS's ROE of +0.06%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to EXIDEIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check EXIDEIND.NS's competition here
SHARDAMOTR.BO vs EXIDEIND.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, EXIDEIND.BO has a market cap of 328.5B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while EXIDEIND.BO trades at ₹387.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas EXIDEIND.BO's P/E ratio is 32.11. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to EXIDEIND.BO's ROE of +0.06%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to EXIDEIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check EXIDEIND.BO's competition here
SHARDAMOTR.BO vs ZFCVINDIA.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, ZFCVINDIA.NS has a market cap of 292B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while ZFCVINDIA.NS trades at ₹2,566.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas ZFCVINDIA.NS's P/E ratio is 12.26. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to ZFCVINDIA.NS's ROE of +0.15%. Regarding short-term risk, SHARDAMOTR.BO is less volatile compared to ZFCVINDIA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check ZFCVINDIA.NS's competition here
SHARDAMOTR.BO vs ZFCVINDIA.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, ZFCVINDIA.BO has a market cap of 291.6B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while ZFCVINDIA.BO trades at ₹2,561.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas ZFCVINDIA.BO's P/E ratio is 12.24. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to ZFCVINDIA.BO's ROE of +0.15%. Regarding short-term risk, SHARDAMOTR.BO is less volatile compared to ZFCVINDIA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check ZFCVINDIA.BO's competition here
SHARDAMOTR.BO vs TVSHLTD.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, TVSHLTD.NS has a market cap of 276.7B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while TVSHLTD.NS trades at ₹13,678.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas TVSHLTD.NS's P/E ratio is 16.32. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to TVSHLTD.NS's ROE of +0.25%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to TVSHLTD.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check TVSHLTD.NS's competition here
SHARDAMOTR.BO vs TVSHLTD.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, TVSHLTD.BO has a market cap of 275.5B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while TVSHLTD.BO trades at ₹13,671.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas TVSHLTD.BO's P/E ratio is 16.31. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to TVSHLTD.BO's ROE of +0.25%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to TVSHLTD.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check TVSHLTD.BO's competition here
SHARDAMOTR.BO vs APOLLOTYRE.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, APOLLOTYRE.BO has a market cap of 273.4B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while APOLLOTYRE.BO trades at ₹430.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas APOLLOTYRE.BO's P/E ratio is 14.74. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to APOLLOTYRE.BO's ROE of +0.09%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to APOLLOTYRE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check APOLLOTYRE.BO's competition here
SHARDAMOTR.BO vs APOLLOTYRE.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, APOLLOTYRE.NS has a market cap of 273.2B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while APOLLOTYRE.NS trades at ₹430.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas APOLLOTYRE.NS's P/E ratio is 13.53. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to APOLLOTYRE.NS's ROE of +0.09%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to APOLLOTYRE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check APOLLOTYRE.NS's competition here
SHARDAMOTR.BO vs MSUMI.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, MSUMI.NS has a market cap of 266.1B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while MSUMI.NS trades at ₹40.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas MSUMI.NS's P/E ratio is 41.57. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to MSUMI.NS's ROE of +0.34%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to MSUMI.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check MSUMI.NS's competition here
SHARDAMOTR.BO vs MSUMI.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, MSUMI.BO has a market cap of 264.5B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while MSUMI.BO trades at ₹40.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas MSUMI.BO's P/E ratio is 41.58. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to MSUMI.BO's ROE of +0.34%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to MSUMI.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check MSUMI.BO's competition here
SHARDAMOTR.BO vs CRAFTSMAN.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, CRAFTSMAN.BO has a market cap of 248B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while CRAFTSMAN.BO trades at ₹9,456.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas CRAFTSMAN.BO's P/E ratio is 57.12. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to CRAFTSMAN.BO's ROE of +0.13%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to CRAFTSMAN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check CRAFTSMAN.BO's competition here
SHARDAMOTR.BO vs CRAFTSMAN.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, CRAFTSMAN.NS has a market cap of 247.4B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while CRAFTSMAN.NS trades at ₹9,460.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas CRAFTSMAN.NS's P/E ratio is 56.58. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to CRAFTSMAN.NS's ROE of +0.13%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to CRAFTSMAN.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check CRAFTSMAN.NS's competition here
SHARDAMOTR.BO vs ASAHIINDIA.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, ASAHIINDIA.BO has a market cap of 217.3B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while ASAHIINDIA.BO trades at ₹850.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas ASAHIINDIA.BO's P/E ratio is 62.40. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to ASAHIINDIA.BO's ROE of +0.11%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to ASAHIINDIA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check ASAHIINDIA.BO's competition here
SHARDAMOTR.BO vs BELRISE.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, BELRISE.NS has a market cap of 212.3B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while BELRISE.NS trades at ₹238.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas BELRISE.NS's P/E ratio is 54.22. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to BELRISE.NS's ROE of +0.13%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to BELRISE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check BELRISE.NS's competition here
SHARDAMOTR.BO vs BELRISE.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, BELRISE.BO has a market cap of 211.6B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while BELRISE.BO trades at ₹237.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas BELRISE.BO's P/E ratio is 54.03. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to BELRISE.BO's ROE of +0.13%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to BELRISE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check BELRISE.BO's competition here
SHARDAMOTR.BO vs SUNDRMFAST.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, SUNDRMFAST.NS has a market cap of 196.3B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while SUNDRMFAST.NS trades at ₹934.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas SUNDRMFAST.NS's P/E ratio is 33.72. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to SUNDRMFAST.NS's ROE of +0.15%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to SUNDRMFAST.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check SUNDRMFAST.NS's competition here
SHARDAMOTR.BO vs SUNDRMFAST.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, SUNDRMFAST.BO has a market cap of 195.1B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while SUNDRMFAST.BO trades at ₹930.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas SUNDRMFAST.BO's P/E ratio is 33.02. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to SUNDRMFAST.BO's ROE of +0.15%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to SUNDRMFAST.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check SUNDRMFAST.BO's competition here
SHARDAMOTR.BO vs MAHINDCIE.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, MAHINDCIE.NS has a market cap of 194.2B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while MAHINDCIE.NS trades at ₹512.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas MAHINDCIE.NS's P/E ratio is 30.59. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to MAHINDCIE.NS's ROE of +0.20%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to MAHINDCIE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check MAHINDCIE.NS's competition here
SHARDAMOTR.BO vs SHRIPISTON.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, SHRIPISTON.NS has a market cap of 184.5B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while SHRIPISTON.NS trades at ₹4,187.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas SHRIPISTON.NS's P/E ratio is 32.21. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to SHRIPISTON.NS's ROE of +0.21%. Regarding short-term risk, SHARDAMOTR.BO is less volatile compared to SHRIPISTON.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check SHRIPISTON.NS's competition here
SHARDAMOTR.BO vs GABRIEL.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, GABRIEL.NS has a market cap of 178B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while GABRIEL.NS trades at ₹1,239.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas GABRIEL.NS's P/E ratio is 70.82. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to GABRIEL.NS's ROE of +0.20%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to GABRIEL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check GABRIEL.NS's competition here
SHARDAMOTR.BO vs GABRIEL.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, GABRIEL.BO has a market cap of 177.9B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while GABRIEL.BO trades at ₹1,239.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas GABRIEL.BO's P/E ratio is 69.08. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to GABRIEL.BO's ROE of +0.20%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to GABRIEL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check GABRIEL.BO's competition here
SHARDAMOTR.BO vs CIEINDIA.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, CIEINDIA.BO has a market cap of 174.8B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while CIEINDIA.BO trades at ₹457.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas CIEINDIA.BO's P/E ratio is 20.68. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to CIEINDIA.BO's ROE of +0.13%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to CIEINDIA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check CIEINDIA.BO's competition here
SHARDAMOTR.BO vs CIEINDIA.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, CIEINDIA.NS has a market cap of 173.7B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while CIEINDIA.NS trades at ₹457.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas CIEINDIA.NS's P/E ratio is 20.01. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to CIEINDIA.NS's ROE of +0.13%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to CIEINDIA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check CIEINDIA.NS's competition here
SHARDAMOTR.BO vs JBMA.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, JBMA.NS has a market cap of 165B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while JBMA.NS trades at ₹697.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas JBMA.NS's P/E ratio is 78.14. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to JBMA.NS's ROE of +0.15%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to JBMA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check JBMA.NS's competition here
SHARDAMOTR.BO vs JBMA.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, JBMA.BO has a market cap of 164.9B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while JBMA.BO trades at ₹697.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas JBMA.BO's P/E ratio is 78.06. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to JBMA.BO's ROE of +0.15%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to JBMA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check JBMA.BO's competition here
SHARDAMOTR.BO vs MINDACORP.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, MINDACORP.NS has a market cap of 164B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while MINDACORP.NS trades at ₹696.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas MINDACORP.NS's P/E ratio is 46.58. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to MINDACORP.NS's ROE of +0.15%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to MINDACORP.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check MINDACORP.NS's competition here
SHARDAMOTR.BO vs MINDACORP.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, MINDACORP.BO has a market cap of 163.9B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while MINDACORP.BO trades at ₹697.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas MINDACORP.BO's P/E ratio is 46.73. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to MINDACORP.BO's ROE of +0.15%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to MINDACORP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check MINDACORP.BO's competition here
SHARDAMOTR.BO vs MAHSCOOTER.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, MAHSCOOTER.BO has a market cap of 143.4B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while MAHSCOOTER.BO trades at ₹12,516.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas MAHSCOOTER.BO's P/E ratio is 46.07. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to MAHSCOOTER.BO's ROE of +0.01%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to MAHSCOOTER.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check MAHSCOOTER.BO's competition here
SHARDAMOTR.BO vs MAHSCOOTER.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, MAHSCOOTER.NS has a market cap of 142.9B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while MAHSCOOTER.NS trades at ₹12,501.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas MAHSCOOTER.NS's P/E ratio is 43.71. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to MAHSCOOTER.NS's ROE of +0.01%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to MAHSCOOTER.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check MAHSCOOTER.NS's competition here
SHARDAMOTR.BO vs CEATLTD.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, CEATLTD.NS has a market cap of 140.9B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while CEATLTD.NS trades at ₹3,482.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas CEATLTD.NS's P/E ratio is 19.96. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to CEATLTD.NS's ROE of +0.15%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to CEATLTD.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check CEATLTD.NS's competition here
SHARDAMOTR.BO vs CEATLTD.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, CEATLTD.BO has a market cap of 140.4B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while CEATLTD.BO trades at ₹3,480.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas CEATLTD.BO's P/E ratio is 18.40. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to CEATLTD.BO's ROE of +0.15%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to CEATLTD.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check CEATLTD.BO's competition here
SHARDAMOTR.BO vs JKTYRE.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, JKTYRE.NS has a market cap of 113.6B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while JKTYRE.NS trades at ₹394.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas JKTYRE.NS's P/E ratio is 13.74. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to JKTYRE.NS's ROE of +0.15%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to JKTYRE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check JKTYRE.NS's competition here
SHARDAMOTR.BO vs JKTYRE.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, JKTYRE.BO has a market cap of 113.5B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while JKTYRE.BO trades at ₹393.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas JKTYRE.BO's P/E ratio is 11.85. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to JKTYRE.BO's ROE of +0.15%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to JKTYRE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check JKTYRE.BO's competition here
SHARDAMOTR.BO vs SUNCLAYLTD.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, SUNCLAYLTD.NS has a market cap of 109.8B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while SUNCLAYLTD.NS trades at ₹5,426.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas SUNCLAYLTD.NS's P/E ratio is 16.90. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to SUNCLAYLTD.NS's ROE of +0.07%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to SUNCLAYLTD.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check SUNCLAYLTD.NS's competition here
SHARDAMOTR.BO vs LUMAXTECH.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, LUMAXTECH.NS has a market cap of 104.5B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while LUMAXTECH.NS trades at ₹1,533.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas LUMAXTECH.NS's P/E ratio is 35.09. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to LUMAXTECH.NS's ROE of +0.25%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to LUMAXTECH.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check LUMAXTECH.NS's competition here
SHARDAMOTR.BO vs LUMAXTECH.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, LUMAXTECH.BO has a market cap of 104.4B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while LUMAXTECH.BO trades at ₹1,532.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas LUMAXTECH.BO's P/E ratio is 37.48. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to LUMAXTECH.BO's ROE of +0.25%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to LUMAXTECH.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check LUMAXTECH.BO's competition here
SHARDAMOTR.BO vs VARROC.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, VARROC.BO has a market cap of 97B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while VARROC.BO trades at ₹633.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas VARROC.BO's P/E ratio is 34.84. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to VARROC.BO's ROE of +0.14%. Regarding short-term risk, SHARDAMOTR.BO is less volatile compared to VARROC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check VARROC.BO's competition here
SHARDAMOTR.BO vs VARROC.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, VARROC.NS has a market cap of 96.7B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while VARROC.NS trades at ₹633.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas VARROC.NS's P/E ratio is 38.76. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to VARROC.NS's ROE of +0.14%. Regarding short-term risk, SHARDAMOTR.BO is less volatile compared to VARROC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check VARROC.NS's competition here
SHARDAMOTR.BO vs BANCOINDIA.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, BANCOINDIA.BO has a market cap of 95.9B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while BANCOINDIA.BO trades at ₹670.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas BANCOINDIA.BO's P/E ratio is 20.04. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to BANCOINDIA.BO's ROE of +0.33%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to BANCOINDIA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check BANCOINDIA.BO's competition here
SHARDAMOTR.BO vs BANCOINDIA.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, BANCOINDIA.NS has a market cap of 95.9B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while BANCOINDIA.NS trades at ₹670.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas BANCOINDIA.NS's P/E ratio is 20.05. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to BANCOINDIA.NS's ROE of +0.33%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to BANCOINDIA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check BANCOINDIA.NS's competition here
SHARDAMOTR.BO vs ASKAUTOLTD.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, ASKAUTOLTD.NS has a market cap of 88.6B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while ASKAUTOLTD.NS trades at ₹449.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas ASKAUTOLTD.NS's P/E ratio is 32.16. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to ASKAUTOLTD.NS's ROE of +0.26%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to ASKAUTOLTD.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check ASKAUTOLTD.NS's competition here
SHARDAMOTR.BO vs ASKAUTOLTD.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, ASKAUTOLTD.BO has a market cap of 88.5B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while ASKAUTOLTD.BO trades at ₹449.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas ASKAUTOLTD.BO's P/E ratio is 32.15. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to ASKAUTOLTD.BO's ROE of +0.26%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to ASKAUTOLTD.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check ASKAUTOLTD.BO's competition here
SHARDAMOTR.BO vs PRICOLLTD.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, PRICOLLTD.BO has a market cap of 73.4B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while PRICOLLTD.BO trades at ₹603.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas PRICOLLTD.BO's P/E ratio is 29.57. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to PRICOLLTD.BO's ROE of +0.23%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to PRICOLLTD.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check PRICOLLTD.BO's competition here
SHARDAMOTR.BO vs PRICOLLTD.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, PRICOLLTD.NS has a market cap of 73.4B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while PRICOLLTD.NS trades at ₹602.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas PRICOLLTD.NS's P/E ratio is 29.60. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to PRICOLLTD.NS's ROE of +0.23%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to PRICOLLTD.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check PRICOLLTD.NS's competition here
SHARDAMOTR.BO vs BENGALASM.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, BENGALASM.BO has a market cap of 72B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while BENGALASM.BO trades at ₹6,316.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas BENGALASM.BO's P/E ratio is 2.31. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to BENGALASM.BO's ROE of +0.08%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to BENGALASM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check BENGALASM.BO's competition here
SHARDAMOTR.BO vs SJS.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, SJS.NS has a market cap of 71B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while SJS.NS trades at ₹2,218.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas SJS.NS's P/E ratio is 41.01. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to SJS.NS's ROE of +0.23%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to SJS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check SJS.NS's competition here
SHARDAMOTR.BO vs SJS.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, SJS.BO has a market cap of 70.8B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while SJS.BO trades at ₹2,216.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas SJS.BO's P/E ratio is 41.55. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to SJS.BO's ROE of +0.23%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to SJS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check SJS.BO's competition here
SHARDAMOTR.BO vs DYNAMATECH.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, DYNAMATECH.NS has a market cap of 70.6B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while DYNAMATECH.NS trades at ₹10,393.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas DYNAMATECH.NS's P/E ratio is 217.75. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to DYNAMATECH.NS's ROE of +0.04%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to DYNAMATECH.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check DYNAMATECH.NS's competition here
SHARDAMOTR.BO vs DYNAMATECH.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, DYNAMATECH.BO has a market cap of 70.5B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while DYNAMATECH.BO trades at ₹10,397.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas DYNAMATECH.BO's P/E ratio is 217.85. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to DYNAMATECH.BO's ROE of +0.04%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to DYNAMATECH.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check DYNAMATECH.BO's competition here
SHARDAMOTR.BO vs SUPRAJIT.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, SUPRAJIT.BO has a market cap of 63.4B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while SUPRAJIT.BO trades at ₹460.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas SUPRAJIT.BO's P/E ratio is 33.12. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to SUPRAJIT.BO's ROE of +0.14%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to SUPRAJIT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check SUPRAJIT.BO's competition here
SHARDAMOTR.BO vs SUPRAJIT.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, SUPRAJIT.NS has a market cap of 63.2B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while SUPRAJIT.NS trades at ₹460.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas SUPRAJIT.NS's P/E ratio is 35.98. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to SUPRAJIT.NS's ROE of +0.14%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to SUPRAJIT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check SUPRAJIT.NS's competition here
SHARDAMOTR.BO vs FIEMIND.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, FIEMIND.BO has a market cap of 59.5B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while FIEMIND.BO trades at ₹2,261.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas FIEMIND.BO's P/E ratio is 23.33. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to FIEMIND.BO's ROE of +0.23%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to FIEMIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check FIEMIND.BO's competition here
SHARDAMOTR.BO vs FIEMIND.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, FIEMIND.NS has a market cap of 59.5B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while FIEMIND.NS trades at ₹2,261.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas FIEMIND.NS's P/E ratio is 23.83. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to FIEMIND.NS's ROE of +0.23%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to FIEMIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check FIEMIND.NS's competition here
SHARDAMOTR.BO vs SUBROS.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, SUBROS.BO has a market cap of 55B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while SUBROS.BO trades at ₹843.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas SUBROS.BO's P/E ratio is 31.60. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to SUBROS.BO's ROE of +0.14%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to SUBROS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check SUBROS.BO's competition here
SHARDAMOTR.BO vs SUBROS.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, SUBROS.NS has a market cap of 55B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while SUBROS.NS trades at ₹842.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas SUBROS.NS's P/E ratio is 30.57. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to SUBROS.NS's ROE of +0.14%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to SUBROS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check SUBROS.NS's competition here
SHARDAMOTR.BO vs JAMNAAUTO.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, JAMNAAUTO.NS has a market cap of 52.5B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while JAMNAAUTO.NS trades at ₹131.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas JAMNAAUTO.NS's P/E ratio is 21.90. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to JAMNAAUTO.NS's ROE of +0.22%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to JAMNAAUTO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check JAMNAAUTO.NS's competition here
SHARDAMOTR.BO vs JAMNAAUTO.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, JAMNAAUTO.BO has a market cap of 52.3B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while JAMNAAUTO.BO trades at ₹131.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas JAMNAAUTO.BO's P/E ratio is 22.46. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to JAMNAAUTO.BO's ROE of +0.22%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to JAMNAAUTO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check JAMNAAUTO.BO's competition here
SHARDAMOTR.BO vs LGBBROSLTD.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, LGBBROSLTD.BO has a market cap of 51.7B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while LGBBROSLTD.BO trades at ₹1,593.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas LGBBROSLTD.BO's P/E ratio is 15.58. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to LGBBROSLTD.BO's ROE of +0.16%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to LGBBROSLTD.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check LGBBROSLTD.BO's competition here
SHARDAMOTR.BO vs LGBBROSLTD.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, LGBBROSLTD.NS has a market cap of 50.9B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while LGBBROSLTD.NS trades at ₹1,595.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas LGBBROSLTD.NS's P/E ratio is 16.05. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to LGBBROSLTD.NS's ROE of +0.16%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to LGBBROSLTD.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check LGBBROSLTD.NS's competition here
SHARDAMOTR.BO vs SHARDAMOTR.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, SHARDAMOTR.NS has a market cap of 49.9B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while SHARDAMOTR.NS trades at ₹869.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas SHARDAMOTR.NS's P/E ratio is 11.89. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to SHARDAMOTR.NS's ROE of +0.30%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to SHARDAMOTR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check SHARDAMOTR.NS's competition here
SHARDAMOTR.BO vs LUMAXIND.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, LUMAXIND.BO has a market cap of 49.9B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while LUMAXIND.BO trades at ₹5,263.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas LUMAXIND.BO's P/E ratio is 25.98. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to LUMAXIND.BO's ROE of +0.21%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to LUMAXIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check LUMAXIND.BO's competition here
SHARDAMOTR.BO vs LUMAXIND.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, LUMAXIND.NS has a market cap of 49.3B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while LUMAXIND.NS trades at ₹5,278.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas LUMAXIND.NS's P/E ratio is 25.03. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to LUMAXIND.NS's ROE of +0.21%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to LUMAXIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check LUMAXIND.NS's competition here
SHARDAMOTR.BO vs SWARAJENG.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, SWARAJENG.BO has a market cap of 48.8B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while SWARAJENG.BO trades at ₹3,996.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas SWARAJENG.BO's P/E ratio is 24.73. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to SWARAJENG.BO's ROE of +0.46%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to SWARAJENG.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check SWARAJENG.BO's competition here
SHARDAMOTR.BO vs SWARAJENG.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, SWARAJENG.NS has a market cap of 48.6B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while SWARAJENG.NS trades at ₹3,997.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas SWARAJENG.NS's P/E ratio is 27.90. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to SWARAJENG.NS's ROE of +0.46%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to SWARAJENG.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check SWARAJENG.NS's competition here
SHARDAMOTR.BO vs WHEELS.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, WHEELS.BO has a market cap of 43.8B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while WHEELS.BO trades at ₹1,786.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas WHEELS.BO's P/E ratio is 28.16. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to WHEELS.BO's ROE of +0.16%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to WHEELS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check WHEELS.BO's competition here
SHARDAMOTR.BO vs WHEELS.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, WHEELS.NS has a market cap of 43.6B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while WHEELS.NS trades at ₹1,786.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas WHEELS.NS's P/E ratio is 26.66. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to WHEELS.NS's ROE of +0.16%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to WHEELS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check WHEELS.NS's competition here
SHARDAMOTR.BO vs NRBBEARING.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, NRBBEARING.BO has a market cap of 43.2B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while NRBBEARING.BO trades at ₹444.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas NRBBEARING.BO's P/E ratio is 31.09. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to NRBBEARING.BO's ROE of +0.15%. Regarding short-term risk, SHARDAMOTR.BO is less volatile compared to NRBBEARING.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check NRBBEARING.BO's competition here
SHARDAMOTR.BO vs SANDHAR.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, SANDHAR.NS has a market cap of 43.2B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while SANDHAR.NS trades at ₹716.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas SANDHAR.NS's P/E ratio is 21.41. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to SANDHAR.NS's ROE of +0.16%. Regarding short-term risk, SHARDAMOTR.BO is less volatile compared to SANDHAR.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check SANDHAR.NS's competition here
SHARDAMOTR.BO vs SANDHAR.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, SANDHAR.BO has a market cap of 43.1B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while SANDHAR.BO trades at ₹716.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas SANDHAR.BO's P/E ratio is 21.43. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to SANDHAR.BO's ROE of +0.16%. Regarding short-term risk, SHARDAMOTR.BO is less volatile compared to SANDHAR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check SANDHAR.BO's competition here
SHARDAMOTR.BO vs NRBBEARING.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, NRBBEARING.NS has a market cap of 43B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while NRBBEARING.NS trades at ₹444.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas NRBBEARING.NS's P/E ratio is 31.05. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to NRBBEARING.NS's ROE of +0.15%. Regarding short-term risk, SHARDAMOTR.BO is less volatile compared to NRBBEARING.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check NRBBEARING.NS's competition here
SHARDAMOTR.BO vs JTEKTINDIA.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, JTEKTINDIA.NS has a market cap of 37.8B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while JTEKTINDIA.NS trades at ₹136.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas JTEKTINDIA.NS's P/E ratio is 41.70. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to JTEKTINDIA.NS's ROE of +0.08%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to JTEKTINDIA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check JTEKTINDIA.NS's competition here
SHARDAMOTR.BO vs JTEKTINDIA.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, JTEKTINDIA.BO has a market cap of 37.7B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while JTEKTINDIA.BO trades at ₹136.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas JTEKTINDIA.BO's P/E ratio is 43.94. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to JTEKTINDIA.BO's ROE of +0.08%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to JTEKTINDIA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check JTEKTINDIA.BO's competition here
SHARDAMOTR.BO vs SSWL.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, SSWL.NS has a market cap of 36.3B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while SSWL.NS trades at ₹230.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas SSWL.NS's P/E ratio is 16.69. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to SSWL.NS's ROE of +0.11%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to SSWL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check SSWL.NS's competition here
SHARDAMOTR.BO vs SSWL.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, SSWL.BO has a market cap of 36.2B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while SSWL.BO trades at ₹230.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas SSWL.BO's P/E ratio is 18.69. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to SSWL.BO's ROE of +0.11%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to SSWL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check SSWL.BO's competition here
SHARDAMOTR.BO vs RML.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, RML.BO has a market cap of 32B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while RML.BO trades at ₹1,156.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas RML.BO's P/E ratio is 29.74. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to RML.BO's ROE of +0.16%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to RML.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check RML.BO's competition here
SHARDAMOTR.BO vs RML.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, RML.NS has a market cap of 31.9B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while RML.NS trades at ₹1,155.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas RML.NS's P/E ratio is 31.82. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to RML.NS's ROE of +0.16%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to RML.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check RML.NS's competition here
SHARDAMOTR.BO vs TVSSRICHAK.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, TVSSRICHAK.NS has a market cap of 31.5B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while TVSSRICHAK.NS trades at ₹4,107.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas TVSSRICHAK.NS's P/E ratio is 39.46. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to TVSSRICHAK.NS's ROE of +0.06%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to TVSSRICHAK.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check TVSSRICHAK.NS's competition here
SHARDAMOTR.BO vs TVSSRICHAK.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, TVSSRICHAK.BO has a market cap of 31.4B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while TVSSRICHAK.BO trades at ₹4,122.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas TVSSRICHAK.BO's P/E ratio is 37.23. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to TVSSRICHAK.BO's ROE of +0.06%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to TVSSRICHAK.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check TVSSRICHAK.BO's competition here
SHARDAMOTR.BO vs CARRARO.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, CARRARO.NS has a market cap of 30.4B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while CARRARO.NS trades at ₹534.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas CARRARO.NS's P/E ratio is 23.24. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to CARRARO.NS's ROE of +0.26%. Regarding short-term risk, SHARDAMOTR.BO is more volatile compared to CARRARO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check CARRARO.NS's competition here
SHARDAMOTR.BO vs DIVGIITTS.BO Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, DIVGIITTS.BO has a market cap of 30.2B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while DIVGIITTS.BO trades at ₹990.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas DIVGIITTS.BO's P/E ratio is 75.20. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to DIVGIITTS.BO's ROE of +0.08%. Regarding short-term risk, SHARDAMOTR.BO is less volatile compared to DIVGIITTS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check DIVGIITTS.BO's competition here
SHARDAMOTR.BO vs DIVGIITTS.NS Comparison July 2026
SHARDAMOTR.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHARDAMOTR.BO stands at 49.9B. In comparison, DIVGIITTS.NS has a market cap of 30.2B. Regarding current trading prices, SHARDAMOTR.BO is priced at ₹869.60, while DIVGIITTS.NS trades at ₹987.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHARDAMOTR.BO currently has a P/E ratio of 9.46, whereas DIVGIITTS.NS's P/E ratio is 79.90. In terms of profitability, SHARDAMOTR.BO's ROE is +0.33%, compared to DIVGIITTS.NS's ROE of +0.08%. Regarding short-term risk, SHARDAMOTR.BO is less volatile compared to DIVGIITTS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SHARDAMOTR.BO.Check DIVGIITTS.NS's competition here